ARCHIVES

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | November 27, 2009

Download PDF Visit The Full Archive

Related Articles

DES Exposure Studies Below Payline; NCI Considers Contracts

March 6, 1992

DCT Advisors OK Recompetition Of Drug Contacts

March 15, 1991

CMS Dares Critics To Produce ESA Data; House Bill Seeks To Vacate Coverage Decision.

September 28, 2007

News Analysis: Industry’s Accelerated Recovery Initiative May Push Manufacturers Toward Collusion

October 5, 2012

Missouri Center Director Search Narrowed To Vincent, Wiernik

September 10, 1982

GAO Suggests No Limit On Indirect Costs But Ceiling On Total Costs

September 7, 1979